Related Experiment Video
Updated: Aug 6, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Indirect costs and cost-effectiveness analysis
1Rilernst@aol.com
This study explores the societal perspective in cost-effectiveness analyses (CEAs). It proposes methods for handling indirect costs in complex health interventions and identifies conditions for valid cost-effectiveness conclusions.
Area of Science:
- Health Economics
- Decision Science
- Public Health Policy
Background:
- Cost-effectiveness analyses (CEAs) are crucial for healthcare resource allocation.
- The societal perspective in CEAs incorporates both direct and indirect costs.
- Existing models face challenges in accurately reflecting societal costs.
Purpose of the Study:
- To examine the methodological implications of adopting a societal perspective in CEAs.
- To propose computational procedures for managing indirect costs in complex health intervention planning.
- To clarify the conditions under which cost-effectiveness conclusions are valid from a societal viewpoint.
Main Methods:
- Development of an iterative computational procedure for constraint selection in multi-treatment, multi-illness models.
- Analysis of welfare properties of decision rules under a societal perspective in single-illness, two-treatment models.
- Identification of conditions for maintaining cost-effectiveness validity when switching treatments.
Main Results:
- A proposed iterative procedure helps planners constrain indirect costs while balancing health benefits and cost reductions.
- The societal perspective introduces ambiguities in decision-making for common CEA models.
- Cost-effectiveness conclusions are contingent on not increasing total direct costs when patients switch treatments.
Conclusions:
- Adopting a societal perspective in CEAs requires careful methodological consideration, particularly regarding indirect costs.
- The proposed computational procedure offers a framework for managing societal costs in complex healthcare planning.
- Ensuring no increase in direct costs is critical for the validity of cost-effectiveness findings in simpler decision models.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Methods of Medium Optimization
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
